Fundamentals Hub
▼ FY 2025 Summary Analysis
Annual report ending Dec 31, 2025Overview and Growth
NATURAL HEALTH TRENDS CORP generated $39.78M of revenue in fiscal 2025, with net loss of $882.00K and an operating cash outflow of $6.00M. The $39.78M revenue base provides substantial context for the company’s earnings, cash generation, and capital requirements. Revenue was 7.4% below fiscal 2024 revenue of $42.96M, marking a top-line contraction. The company reported diluted EPS of -$0.08, adding a shareholder-level measure to the absolute income figures considered below. The per-share result recorded a 260.0% decrease from fiscal 2024 diluted EPS of $0.05. The company employed $38.43M of total assets, the balance-sheet base supporting its current operating and cash-flow results. Asset turnover was 1.04x, relating the company’s annual revenue directly to the total assets reported at the period end.Profitability
After reported cost of revenue, the company retained $29.25M as gross profit before recognizing operating expenses and other items. Gross margin was 73.5%, so that share of each revenue unit remained after the cost of revenue reported for the period. The company recorded an operating loss of $1.81M after the reported operating expense base. The operating loss equaled 4.5% of revenue, showing the scale of the operating deficit relative to sales. After all below-operating-line items, the company recorded a net loss of $882.00K for the fiscal year. Measured against revenue, the bottom-line deficit represented 2.2% after all recognized items. The pretax result was a loss of $567.00K, establishing the deficit before tax effects. Measured against revenue, the pretax deficit represented 1.4%. The company recognized $315.00K of income tax for the period, completing the transition from pretax income to net income. The net loss equaled 3.8% of period-end equity, showing the deficit relative to book capital. The net loss equaled 2.3% of period-end assets, showing the deficit relative to the asset base. A $882.00K net loss replaced fiscal 2024 net income of $572.00K.Liquidity and Capital Structure
At period end, the $38.43M asset base was financed through $15.00M of liabilities and $23.43M of equity. At period end, current assets of $34.19M compared with current liabilities of $13.69M, defining the company’s short-term resource position. The current ratio was 2.5x, with current assets exceeding current liabilities and providing a short-term liquidity cushion. Reported cash and equivalents were $6.81M, separating immediately recognizable cash resources from the rest of the current-asset base. The cash balance equaled 49.8% of current liabilities, showing how much near-term coverage came from cash alone. Book equity represented 61.0% of total assets, quantifying the balance-sheet share supported by shareholder capital. The liabilities-to-assets relationship was 39.0%, placing reported obligations against the full positive asset balance. Measured against total assets, cash and equivalents represented 17.7%, a balance-sheet composition measure rather than a liquidity forecast. Total assets were 30.6% lower than fiscal 2024 assets of $55.36M, measuring the company’s own balance-sheet change. Reported equity changed 28.7% from $32.87M in fiscal 2024, placing the current capital base lower year over year. Compared with $13.53M in fiscal 2024, the current cash balance moved 49.7% and finished lower.Cash Flow and Earnings Quality
The company reported an operating cash outflow of $6.00M, rather than cash generation from operations. Capital expenditures used $68.00K in addition to the operating cash outflow, increasing the total cash consumed by operations and investment during the period. Operating cash flow and capital spending combined to leave a $6.07M cash deficit after capital spending. The free-cash-flow deficit equaled 15.2% of revenue, showing the post-investment cash shortfall relative to sales. The free-cash-flow deficit equaled 15.8% of total assets, placing the cash shortfall against the company’s resource base.
Based on the annual report for the fiscal year ending Dec 31, 2025.
Analysis generated .